New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
16:27 EDTDG, FINL, MTW, DD, AMED, MNKD, NKEOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a late day rise allowed all of the major averages to end the week on a high note. The averages began the session in negative territory but soon turned mixed. The Nasdaq was able to hold its head above water for most of the session while the Dow struggled for most of the day under the weight of DuPont (DD) shares, which were down more than 3% after the company lowered its guidance. ECONOMIC EVENTS: In the U.S., the final University of Michigan consumer sentiment index for June rose to 82.5, which beat the consensus expectation for a reading of 81.9. COMPANY NEWS: Shares of athletic apparel and footwear giant Nike (NKE) and sports shoe retailer Finish Line (FINL) climbed after both companies reported better than expected quarterly sales and profits. Dow member Nike rose 82c, or 1.07%, to $77.68, while Finish Line advanced 41c, or 1.41%, to $29.56... Another member of the Dow Jones Industrial Average, DuPont, moved in the opposite direction, falling $2.26, or 3.34%, to $65.44 after the industrial conglomerate cut its earnings outlook for its second quarter and its current fiscal year. MAJOR MOVERS: Among the notable gainers was Amedisys (AMED), which rose $4.01, or 29.81%, to $17.46 and was upgraded at CRT Capital after the company gave Q2 guidance. Also higher was Manitowoc (MTW), which gained $3.22, or 10.84%, to $32.93 and was upgraded to Hold at Jefferies after activist Relational Investors took an 8.5% stake in the company and urged for a spin-off of its food business. Among the noteworthy losers was discount retailer Dollar General (DG), which fell $4.49, or 7.28%, to $57.19 after Chief Executive Officer Rick Dreiling announced plans to retire. Also lower were shares of MannKind (MNKD), which dropped 58c, or 5.48%, to $10.00 after the FDA approved its Afrezza inhalation powder to treat diabetes but required the drug to have a Boxed Warning and required the company to conduct several post-marketing studies on the drug. INDEXES: The Dow was up 5.71, or 0.03%, to 16,851.84, the Nasdaq was up 18.88, or 0.43%, to 4,397.93, and the S&P 500 was up 3.74, or 0.19%, to 1,960.96.
News For NKE;DD;FINL;MNKD;MTW;DG;AMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 28, 2015
06:55 EDTDDDuPont sees FY15 Industrial Biosciences revenue down mid-single-digits percent
FY15 Industrial Biosciences sales are expected to be down mid-single-digits percent due to currency. Operating earnings down low-single digits percent as higher volumes, prices and improved mix more than offset by currency.
06:54 EDTDDDuPont sees Q3 Industrial Biosciences revenue down low single digit percent
Subscribe for More Information
06:51 EDTDDDuPont sees FY15 Nutrition & Health revenue mid-single digits percent lower
Subscribe for More Information
06:50 EDTDDDuPont sees Q3 Nutrition & Health revenue down mid-single digits percent
Subscribe for More Information
06:48 EDTDDDuPont sees FY15 E&C revenue down high-single digits pecent
Subscribe for More Information
06:47 EDTDDDuPont sees Q3 Electronics & Communications revenue down low-teens percent
Subscribe for More Information
06:31 EDTDDDuPont sees FY15 Performance Materials revenue down about 10%
Sees FY15 Performance Materials sales down about 10% due primarily to currency, portfolio changes, and lower ethylene prices. Operating earnings down mid-single digits percent as volume growth is more than offset by the negative impacts from currency and portfolio.
06:30 EDTDDDuPont sees FY15 revenue mid-to-high single digits
DuPont sees FY15 net sales down mid-to-high single digits due to impact of currency, portfolio changes, and a challenging Agriculture environment. Sees FY15 base tax rate 22%. Sees FY15 CapEx, ex-performance chemicals about $1.5B.
06:30 EDTDDDuPont sees Q3 Performance Materials revenue down about 10%
Subscribe for More Information
06:21 EDTDDDuPont lowers Q3 dividend to 38c per share from 49c per share
Subscribe for More Information
06:04 EDTDDDuPont sees FY15 EPS about $3.10, consensus $3.54
Subscribe for More Information
06:02 EDTDDDuPont reports Q2 EPS $1.18, consensus $1.18
Reports Q2 revenue $8.6B, consensus $8.75B.
July 27, 2015
15:38 EDTDDTrian's Peltz still looking to replace DuPont CEO, Charles Gasparino says
Subscribe for More Information
15:03 EDTDDNotable companies reporting before tomorrow's open
Subscribe for More Information
10:00 EDTMTWOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:41 EDTDDDuPont price target lowered to $67 from $88 at Susquehanna
Susquehanna lowered its price target on DuPont (DD) to $67 from $88 following the separation of Chemours (CC). Susquehanna maintained its Positive rating on DuPont shares.
06:43 EDTMTWManitowoc downgraded to Sell from Neutral at Goldman
Subscribe for More Information
06:36 EDTNKENike to pay $2.4M to FuelBand customers, AppleInsider reports
Under terms agreed upon in June, Nike (NKE) will pay $2.4M to customers who purchased a FuelBand product anytime between January 19, 2012 and June 17, 2015 to settle a class action suit leveled against itself and Apple (AAPL) in 2013, AppleInsider reports. Apple was named as a defendant in the suit, but holds no responsibility or liability for attorneys' fees or costs, the report says. The plaintiffs alleged that the Fuelband was unable to accurately track calorie burn, steps, and overall activity, the report says. Reference Link
July 24, 2015
11:24 EDTFINLFinish Line management to meet with Buckingham
Meetings to be held in Los Angeles on July 27 and in San Francisco on July 28 hosted by Buckingham.
July 23, 2015
06:09 EDTDDColfax names Matthew Trerotola CEO
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use